Juno Therapeutics (juno) Priced

Developing T-cell therapies for lymphomas, leukemias and other cancers.

Health Care - Biotechnology

IPO Performance
Latest Trade $23.18 +0.05 (+0.2%)
First Day Return 45.8%
Return from IPO -3.6%
 
Juno Therapeutics IPO News more
  • .
IPO Data
IPO File Date 11/17/2014
Offer Price $24.00
Price Range $21.00 - $23.00
Offer Shares (mm) 11.0
Deal Size ($mm) 265
 
IPO Data
IPO Date 12/18/2014
Offer Price $24.00
Price Range $21.00 - $23.00
Offer Shares (mm) 11.0
Deal Size ($mm) $265
 
Underwriters
more
Business Overview
Developing T-cell therapies for lymphomas, leukemias and other cancers.
Developing T-cell therapies for lymphomas, leukemias and other cancers.
more
Company Data
Headquarters Seattle, WA
Founded 2013
Employees 70
Website www.junotherapeutics.com
 

Performance vs. IPO Index (IPOUSA)